Initial Statement of Beneficial Ownership (Form 3)

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Zeif Yoav 2. Date of Event Requiring Statement (Month/Day/Year) 03/18/2026 3. Issuer Name and Ticker or Trading Symbol STRATASYS LTD. [SSYS] (Last) (First) (Middle) C/O STRATASYS LTD., 1 HOLTZMAN STREET, SCIENCE PARK 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Executive Officer 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) REHOVOT 76124 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Ordinary shares 151,083 D Ordinary shares(1) 36,667 D Ordinary shares(2) 36,667 D Ordinary shares(3) 36,667 D Ordinary shares(4) 70,475 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy ordinary shares)	(5)	02/18/2030	Ordinary shares	150,000	$16.41	D
Stock Option (right to buy ordinary shares)	(6)	02/18/2030	Ordinary shares	150,000	$16.41	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Zeif Yoav C/O STRATASYS LTD. 1 HOLTZMAN STREET, SCIENCE PARK REHOVOT 76124			Chief Executive Officer

Signatures

/s/ Vered Ben Jacob, attorney-in-fact		03/18/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person on March 1, 2023 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vest upon the one-year anniversary of the grant date, and the remaining RSUs vest equally on a quarterly basis over the following twelve quarters (6.25% per quarter) whereby all such RSUs will be fully vested (and underlying ordinary shares issued) by the four-year anniversary of the grant date.
(2)	The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on December 21, 2023 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vest upon the one-year anniversary of the grant date and the remaining RSUs vest equally on a quarterly basis over the following twelve quarters (6.25% per quarter) whereby all such RSUs will be fully vested (and underlying ordinary shares issued) by the four-year anniversary of the grant date.
(3)	The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on December 19, 2024 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vest upon the one-year anniversary of the grant date and the remaining RSUs vest equally on a quarterly basis over the following twelve quarters (6.25% per quarter) whereby all such RSUs will be fully vested (and underlying ordinary shares issued) by the four-year anniversary of the grant date.
(4)	The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on September 30, 2025 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vest upon the one-year anniversary of the grant date and the remaining RSUs vest equally on a quarterly basis over the following twelve quarters (6.25% per quarter) whereby all such RSUs will be fully vested (and underlying ordinary shares issued) by the four-year anniversary of the grant date.
(5)	The options reported in this row were granted to the Reporting Person by the Issuer on February 18, 2020 and vest and become exercisable subject to the Issuer's share price reaching a certain level, in equal installments of 18,750 options each over a period of eight quarters following achievement of the share price level, such that at the end of such eight quarter period all 150,000 options will be fully vested and exercisable.
(6)	The options reported in this row were granted to the Reporting Person by the Issuer on February 18, 2020 and vest and become exercisable subject to the Issuer's share price reaching a certain level, in equal installments of 18,750 options each over a period of eight quarters following achievement of the share price level, such that at the end of such eight quarter period all 150,000 options will be fully vested and exercisable.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.